Connectionohsign up
to access my account features
my account area
Find similar products:
the same active ingredient
the same company
With ATC code
see changes
Add to favorites
Share via email
side effect report
Report a suspicious side effect or counterfeit product to the MHRA yellow card system.
go back up
Clarithromycin 250 mg film-coated tablets
Active ingredient:
clarithromycin
Company:
Ranbaxy (UK) Limited, a Sun pharmaceutical company See contact details
ATC Code:
J01FA09
About Medicine
prescription drugs only
my account area

Connectionohsign up
to access my account features
Find similar products:
the same active ingredient
the same company
With ATC code
see changes
Add to favorites
Share via email
Health Professionals (RCM) Patient Leaflet (PIL) HCP Medical Information
The Patient Information Leaflet (PIL) is the leaflet that comes with the medicine package.
Latest EMC update:October 21, 2022
View or print the patient brochure in PDF format
Below is a text-only representation of the Patient Information Leaflet (ePIL).
text only versionmay be availabletheybig letters,Embossed writing for the blindohCD de audio.For more information, call EMC Accessibility at0800 198 5000.The product code(s) in this brochure is: PL 14894/0159.
Print the patient brochure as text only
Print the patient brochure in large text
Clarithromycin 250 mg film-coated tablets
Instructions for use sheet: Information for the user
Clarithromycin 250 mg film-coated tablets
Please read all of this leaflet carefully before you start taking this medicine as it contains important information for you.
- Keep this brochure. You may have to read it again.
- If you are still not sure, talk to your doctor or pharmacist.
- This medicine has been specially prescribed for you. Do not pass this on to other people. It can hurt them even if the symptoms are the same as yours.
- If you notice any side effects, tell your doctor or pharmacist. This includes any possible side effects not mentioned in this leaflet. See section 4.
What's in this brochure?
1. What clarithromycin film-coated tablets are and what they are used for
2. What you need to know before you take Clarithromycin Accord
3. How to take clarithromycin film-coated tablets
4. Possible side effects
5. How to store Clarithromycin film-coated tablets
6. Package content and other information
1. What clarithromycin film-coated tablets are and what they are used for
Clarithromycin film-coated tablets contain the active ingredient clarithromycin, which is a macrolide antibiotic that prevents the growth of infection-causing bacteria.
Clarithromycin film-coated tablets are indicated for use in adults and adolescents 12 years of age and older for the treatment of infections caused by organisms sensitive to clarithromycin. These infections include:
- Upper respiratory tract infections (eg, pharyngitis, sinusitis)
- Lower respiratory tract infections (eg, bronchitis, pneumonia)
- acute otitis media
- Skin and soft tissue infections (eg, ringworm, folliculitis, cellulitis, abscesses)
- Infections of the teeth and mouth (eg, periapical abscess, periodontitis)
- Disseminated or localized mycobacterial infections.
In HIV-infected patients (CD4 cell count ≤100/mm3), clarithromycin is indicated for the prevention of disseminated infections caused by Mycobacterium avium complex (MAC).
In patients with duodenal ulcer and Helicobacter pylori infection with a confirmed diagnosis, treatment with clarithromycin is recommended simultaneously with preparations that suppress gastric acid secretion and other antibiotics.
2. What you need to know before you take Clarithromycin Accord
Do not take clarithromycin film-coated tablets if:
- if you are allergic to clarithromycin, other macrolide antibiotics such as erythromycin or azithromycin, or any of the other ingredients of this medicine (listed in section 6).
- you are taking ergot alkaloids such as ergotamine or dihydroergotamine (medicines used, among others, to treat migraine headaches) or oral midazolam (a medicine used to treat anxiety and insomnia).
- you are taking medicines that can cause serious heart rhythm disturbances.
- if you are taking astemizole or terfenadine (medicines used to treat allergies), cisapride or domperidone (a medicine used to treat gastrointestinal disorders), pimozide (a medicine used to treat mental disorders), as these may cause serious heart rhythm disturbances when taken together with clarithromycin film-coated tablets.
- you are taking ticagrelor (a medicine that inhibits platelet aggregation) or ranolazine (a heart medicine).
- you have been diagnosed with a low level of potassium or magnesium in your blood (hypokalaemia or hypomagnesaemia).
- you are taking lovastatin or simvastatin (statin medicines used to lower blood cholesterol).
- You have been diagnosed with severe liver failure with concomitant renal failure.
- you have or someone in your family has had a history of heart rhythm disorders (ventricular cardiac arrhythmias, includingtorsades of points) or abnormal results from an electrocardiogram (ECG, a measurement of the heart's electrical activity) called "long QT syndrome."
- you are taking colchicine (a medicine used to treat gout).
- you are taking medicines containing lomitapide.
Warnings and Cautions
Talk to your doctor or pharmacist before taking clarithromycin film-coated tablets:
- if you are pregnant or think you may be pregnant
- if you have a liver or kidney disorder
- if you have been diagnosed with coronary heart disease, severe heart failure or a slow heart rate
- if you are taking any of the medicines listed in the section “Other medicines and clarithromycin film-coated tablets”
If you experience any of the conditions described below while taking clarithromycin film-coated tablets, please tell your doctor.
- Serious hypersensitivity reactions such as macular rash, urticaria, ecchymosis, laryngeal edema, bronchospasm.Immediatelyinform a doctor who will introduce the appropriate treatment.
- Diarrhoea, especially acute or prolonged. Talk to your doctor as soon as possible. If necessary, the doctor will prescribe the appropriate treatment. Do not use anti-diarrheal medicines.
- Symptoms that indicate liver dysfunction, such as loss of appetite, jaundice, dark urine, itching, or stomach pain. Discontinue treatment and inform the doctor.
- New infection (superinfection) with clarithromycin-resistant bacteria or fungi, especially during prolonged use of antibiotics. The doctor will prescribe the appropriate treatment.
Besides,during downloadClarithromycin film-coated tablets that you can feel:
- bacterial cross-resistance (bacteria resistant to clarithromycin may also be resistant to other macrolide antibiotics, as well as lincomycin and clindamycin);
- bacterial resistance to drugs (for example, the treatment ofHelicobacter pyloriinfection can lead to the emergence of drug-resistant microorganisms).
If symptoms suggesting damage to the auditory or labyrinthine organs occur (see section 4), appropriate follow-up testing is recommended after completion of treatment.
Other medicines and clarithromycin film-coated tablets
Tell your doctor if you are taking, have recently taken or might take any other medicines.
You should tell your doctor if you are taking any of the following medicines, as their use with clarithromycin film-coated tablets is contraindicated:
- ergot alkaloids such as ergotamine or dihydroergotamine (medicines used, among others, to treat migraine)
- astemizole or terfenadine (medicines used to treat allergies)
- cisapride or domperidone (a medicine used to treat gastrointestinal disorders)
- pimozide (a medicine used to treat mental disorders)
- ticagrelor, ranolazine (a medicine used to treat heart and circulation problems)
- colchicine (a medicine used to treat gout)
- statins: lovastatin, simvastatin (medicines used to lower blood cholesterol)
- oral midazolam (a medicine used to treat anxiety or insomnia)
Tell your doctor if you are taking any of the following medicines, as special care is needed when using them with clarithromycin film-coated tablets:
- rifampicin, rifapentine, rifabutin (antibiotics used to treat tuberculosis)
- fluconazole, itraconazole (antifungal drugs)
- atazanavir, efavirenz, etravirine, nevirapine, ritonavir, saquinavir, zidovudine (used to treat HIV infection)
- digoxin, quinidine, disopyramide, verapamil, amlodipine, diltiazem (used to treat heart disease or high blood pressure)
- alprazolam, triazolam, midazolam given intravenously or orally (medicines used to treat anxiety or insomnia)
- warfarin or any other anticoagulant, e.g. dabigatran, rivaroxaban, apixaban
- quetiapine or other atypical antipsychotic medication
- carbamazepine, valproate, phenytoin (antiepileptic drugs)
- methylprednisolone (an anti-inflammatory drug)
- omeprazole (a medicine that reduces the secretion of stomach acid)
- cilostazol (a medicine used to treat intermittent claudication manifested as muscle pain in the lower extremities when you strain to take a step back after a short rest)
- ciclosporin, tacrolimus, sirolimus (medicines used, among others, after transplants)
- sildenafil, tadalafil, vardenafil (medicines used to treat erectile dysfunction)
- ibrutinib or vinblastine (drugs used in cancer chemotherapy)
- theophylline (a medicine used to treat asthma)
- tolterodine (a medicine used to treat urinary incontinence)
- phenobarbital (an anti-seizure medication)
- St. John's Wort (an herbal medicine used to treat mild depression)
- Sulfonylurea, nateglinide, repaglinide, insulin (drugs used in diabetes)
- Ototoxic (hearing-damaging) drugs, especially aminoglycoside antibiotics used in bacterial infections.
- hydroxychloroquine and chloroquine (medicines used to treat autoimmune diseases).
Pregnancy and lactation
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, talk to your doctor or pharmacist before using this medicine, as the safety of clarithromycin during pregnancy and breast-feeding is unknown. Clarithromycin film-coated tablets can only be used during pregnancy when, in the opinion of the doctor, the benefit to the mother outweighs the potential risk to the foetus.
Clarithromycin is excreted in human milk, therefore lactating women should be especially careful when taking clarithromycin film-coated tablets.
Drive and operate machines.
This medicine can cause dizziness, lightheadedness, confusion and disorientation, which may affect your ability to drive and use machines. If you are affected, you should not drive or use machinery.
Clarithromycin film-coated tablets contain sodium.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, ie essentially 'sodium-free'.
3. How to take clarithromycin film-coated tablets
Always take this medication exactly as prescribed by your doctor. Talk to your doctor or pharmacist if you are not sure.
Medications for oral use.
Swallow the tablet whole with water. Do not chew or suck on the tablet.
The tablets can be taken with or without food.
If administration of a single 500 mg dose is required, the use of a clarithromycin film-coated tablet containing 500 mg clarithromycin is recommended.
Infections of the respiratory system, skin and soft tissues, acute otitis media.
Adults
One 250 mg tablet twice a day (every 12 hours).
In case of severe infections, your doctor may recommend increasing the dose to two 250 mg tablets (ie 500 mg) twice a day (every 12 hours).
Treatment usually lasts from 5 to 14 days, except in pneumonia and sinusitis, where treatment lasts from 6 to 14 days.
Adolescents older than 12 years
Dose as for adults.
Children 12 years and under
It is recommended to use clarithromycin film-coated tablets in the form of an oral suspension.
Patients with renal dysfunction.
Your doctor may recommend halving your medication dose, which means taking one 250mg tablet once a day.
In case of severe infections – one 250 mg tablet twice a day.
Treatment does not last more than 14 days.
Infections of the teeth and oral cavity.
One 250 mg tablet twice a day (every 12 hours). Treatment usually lasts 5 days.
Infections caused by mycobacteria.
Recommended adult dose: two 250 mg tablets (ie 500 mg) twice a day.
Treatment of a disseminated infection caused bymicobacteria aviumcomplex (MAC) in patients with AIDS should be continued as recommended by the physician. Clarithromycin film-coated tablets should be used in combination with other drugs againstmycobacteria.
Treatment of other non-tuberculous mycobacterial infections should be continued as recommended by the physician.
Prevention of MAC infections
Recommended adult dose: two 250 mg tablets (ie 500 mg) twice a day.
Helicobacter pylori infections
Patients with peptic ulcer or duodenal ulcer caused byHelicobacter pyloriInfection can receive clarithromycin 500 mg twice daily for 7 to 14 days, in combination with additional appropriate antimicrobial therapy and proton pump inhibitors, according to national and international recommendations forHelicobacter pylorielimination.
If you take more Clarithromycin film-coated tablets than you should
If you take more than the recommended dose of clarithromycin film-coated tablets, contact your doctor or pharmacist immediately.
Taking more clarithromycin film-coated tablets than the dose recommended by your doctor may cause gastrointestinal symptoms (vomiting, stomach pain).
If you forget to take Clarithromycin film-coated tablets
If you miss a dose, take it as soon as possible and take another dose at the scheduled time.
Do not take a double dose to make up for a forgotten dose.
Stop taking clarithromycin film-coated tablets
Do not stop taking clarithromycin, even if you feel better. It is important to take the pills for as long as your doctor tells you, otherwise the problem may come back.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Do not stop treatment, even if you feel better and symptoms disappear after several days of using the medicine.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone gets them.
If you experience any of the following side effects at any time during treatment, you shouldI should stop drinkingClarithromycin film-coated tablets and contact a doctor immediately:
- Anaphylactic Shock: An acute life-threatening allergic reaction manifested by, among other things, confusion, pale skin, low blood pressure, sweating, low urine output, rapid breathing, weakness, and fainting.
- allergic reactions: rash (very common), itching, hives (uncommon), angioedema of the face, tongue, lips, eyes and pharynx, difficulty breathing.
- severe skin reactions:
- Acute generalized rash pustule: a red, scaly rash with nodules under the skin and blisters.
- blistering erythema multiforme (Stevens-Johnson syndrome) manifesting as a sudden onset of fever and blistering, which resolves rapidly and spontaneously after stopping the drug. Serious disease manifested by blisters and erosions on the skin, oral cavity, eyes and genitals, fever and joint pain.
- Toxic epidermal necrolysis (Lyell's syndrome): a severe disease with a rapid course characterized by huge blisters that burst under the skin, extensive skin erosions, large layered peeling of the skin, and fever.
- DRESS syndrome: severe (life-threatening) drug-induced skin rash with increased eosinophils and internal organ involvement
- Severe or prolonged diarrhea, possibly with some blood or crusty stools (pseudomembranous colitis). Diarrhea can appear up to two months after finishing treatment with clarithromycin. If this is the case, you should also consult a doctor.
- yellow skin (jaundice), skin irritation, pale stools, dark urine, abdominal tenderness or lack of appetite. These could be symptoms of liver failure, cholestasis (increased bile products in the blood), hepatitis (uncommon).
They occur with unknown frequency unless otherwise stated.
Other side effects
The following side effects (occurring in between 1 and 10 patients in 100) have beenmany timesReported in clinical studies and post-marketing experience with clarithromycin:
- insomnia
- taste disturbances, headache
- diarrhoea, vomiting, indigestion, nausea, abdominal pain
- abnormal liver function results
- excessive sweating
unusual side effects(occurs in 1 to 10 patients in 1,000):
- yeast infection (yeast infection), vaginal infection
- Decreased white blood cells, decreased neutrophils, and increased eosinophils.
- anorexia, decreased appetite
- worry
- dizziness, drowsiness, tremors
- balance disorder, hearing loss, ringing in the ears
- palpitations, changes in the ECG tracing (QT prolongation)
- inflammation of the stomach, inflammation of the mouth, inflammation of the tongue, bloating, constipation, dry mouth, belching, wind
- increased activity of liver enzymes: increased alanine aminotransferase activity, increased aspartate aminotransferase activity, increased γ-glutamyl transferase activity
- malaise, weakness (weakness, lack of energy), chest pain, chills, tiredness
- increased activity of blood enzymes: alkaline phosphatase and lactate dehydrogenase
The frequency of side effects listed below isa stranger(Frequency cannot be estimated from the available data.) Reported from post-marketing experience with clarithromycin film-coated tablets and suspension:
- erysipelas
- agranulocytosis (reduced number of white blood cells in the blood), thrombocytopenia (reduced number of platelets)
- acne
- psychotic disorders, confusional state, depersonalization, depression, disorientation, hallucinations, abnormal dreams, mania
- seizures, lack of taste, changes in smell (parosmia), loss of smell, paraesthesia (numbness, tingling)
- deafness
- type of heart rhythm disorder (twisted ends, ventricular tachycardia, ventricular fibrillation)
- bleeding
- acute inflammation of the pancreas, discoloration of the tongue or teeth;
- myopathy (a muscle disease involving decreased muscle strength)
- renal failure, interstitial nephritis
- change in test results (increased international normalized ratio [INR], prolonged prothrombin time, abnormal urine color)
Immunocompromised patients
In addition to symptoms related to the course of the disease, the following side effects have been observed in immunocompromised adult patients:
- nausea, vomiting, taste disturbances, constipation, abdominal pain, diarrhoea, flatulence, dry mouth
- headache, hearing disorders
- rash
- shortness of breath, insomnia
- Abnormal laboratory test results: increased aspartate aminotransferase (AspAT) and alanine aminotransferase (AlAT) activity, increased blood urea nitrogen, and decreased platelet and white blood cell counts.
report side effects
If you notice any side effects, talk to your doctor or pharmacist. This includes any possible side effects not mentioned in this leaflet.
You can also report adverse reactions directly through the Yellow Card scheme at: www.mhra.gov.uk/amarillocard or search for MHRA Yellow Card on Google Play or the Apple App Store. Reporting side effects can help provide more information about the safety of this medication.
5. How to store Clarithromycin film-coated tablets
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the box and on the blister after EXP. The end date refers to the last day of the given month.
This medicine does not require special storage temperature conditions. Store in the original package in order to protect from moisture.
Do not throw any medicine down the drain or in the trash. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help protect the environment.
6. Package content and other information
What clarithromycin film-coated tablets contain
Each film-coated tablet contains 250 mg clarithromycin.
The other ingredients are microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, talc, colloidal anhydrous silica, stearic acid and Opadry 20H 52875 coating material containing: hypromellose, hydroxypropylene yellow, propylene vanoxide, propylene and propylene. I (E 104)
What Clarithromycin film-coated tablets look like and contents of the pack
Clarithromycin 250 mg film-coated tablets are pale yellow, oval, biconvex, film-coated tablets debossed “C1” on one side.
Clarithromycin film-coated tablets are available in blisters of 1, 2, 10, 1x10, 12, 14, 1x14, 15, 20, 42, 50, 56 or 100 tablets. Not all packages can be published.
Marketing Authorization Holder
Ranbaxy (UK) Limited
5th walk
Oh Hyde Park
Hayes 3
11 Millington Road
Hayes
UB3 4AZ
United Kingdom
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
87 Polarisa Avenue
2132 JH Hoofddorp
Netherlands
Terapia S.A.
factory street
124, Cluj-Napoca
Cluj
400632
Rumania
This brochure was last revised in July 2022.
V047
Ranbaxy (UK) Limited, a Sun pharmaceutical company
ADDRESS
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, Reino Unido
telephone
+44 (0) 208 848 8688
[email protected]
Medical Information Hotline
+44 (0) 208 848 5052
Medical information email.
[email protected]
Out of hours contact
[email protected]